QRG CAPITAL MANAGEMENT, INC.

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 1996454 BERWYN, PA

Position in TAK

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$5,975,214

-$834,367 QoQ

Shares Held

372,752

+1.4% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

of 32 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

QRG CAPITAL MANAGEMENT, INC. holds $23,691,979 across 10 Drug Manufacturers - Specialty & Generic names. TAK ranks #1 (25.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TAK	Takeda Pharmaceutical Co Ltd This page	372,752	$5,975,214
2	ZTS	Zoetis Inc.	54,575	$3,921,759
3	HLN	Haleon plc	383,552	$3,578,540
4	NBIX	Neurocrine Biosciences Inc	18,903	$3,185,911
5	TEVA	Teva Pharmaceutical Industries Ltd	89,078	$3,017,962
6	UTHR	UNITED THERAPEUTICS Corp	3,476	$1,883,401
7	VTRS	Viatris Inc	49,564	$787,076
8	RDY	Dr Reddys Laboratories Ltd	41,233	$597,466

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,975,214	372,752	+1.4%	Shares	Sole	2026-07-14
2026-03-31	$6,809,581	367,688	+27.3%	Shares	Sole	2026-04-27
2025-12-31	$4,501,300	288,730	+2.7%	Shares	Sole	2026-02-02
2025-09-30	$4,115,933	281,143	-35.0%	Shares	Sole	2025-10-28
2025-06-30	$6,688,830	432,654	+11.8%	Shares	Sole	2025-07-21
2025-03-31	$5,753,619	386,928	+17.4%	Shares	Sole	2025-04-17
2024-12-31	$4,364,486	329,644	+16.8%	Shares	Sole	2025-02-05
2024-09-30	$4,012,229	282,154	+4.5%	Shares	Sole	2024-10-30
2024-06-30	$3,495,339	270,119	-14.7%	Shares	Sole	2024-07-12
2024-03-31	$4,399,907	316,768	-1.4%	Shares	Sole	2024-05-07
2023-12-31	$4,585,079	321,309	-9.8%	Shares	Sole	2024-02-07
2023-09-30	$5,511,048	356,241	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.